https://mito2i.ca/award-announcement-nfrft/
TORONTO, ON — April 2025 — The University of Toronto and partner institutions have received a landmark $23.8 million New Frontiers in Research Fund – Transformation (NFRF-T) grant to pioneer mitochondrial transplantation therapy, an emerging field that could redefine how the world treats organ failure, chronic inflammation, and degenerative diseases.
The project, titled MitoRevolution: Mitochondrial Transplantation Transforming Regenerative Medicine — from research to patient care to global impact, is led by Dr. Ana Andreazza, Professor of Pharmacology and Toxicology at U of T’s Temerty Faculty of Medicine and founder & scientific director of the Mitochondrial Innovation Initiative (MITO2i).